LENZ THERAPEUTICS, INC. Current Assets
LENZ THERAPEUTICS, INC. (LENZ) had Current Assets of $233.28 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-11
- 2026-06-30: Assets, Current $233.28M.
- 2026-03-31: Assets, Current $268.37M.
- 2025-12-31: Assets, Current $301.41M.
- 2025-09-30: Assets, Current $207.00M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $233.28M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $268.37M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $301.41M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $207.00M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $213.60M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $197.86M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $211.92M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $220.70M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $199.35M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $216.67M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $67.24M 10-K · filed 2025-03-19 | $188.02M 10-K · filed 2024-02-27 |
| 2023-09-30 | $238.78M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $251.17M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $270.31M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $275.37M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $298.49M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $326.64M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $343.76M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $381.74M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $401.23M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $384.75M 10-Q · filed 2021-08-12 | |
| 2020-12-31 | $21.10M 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |